Evidence map›Paper›PMID 37519572›Full record

ArticleCureus2023

Acute Myocardial Infarction as the First Presentation of Systemic Lupus Erythematosus in a 23-Year-Old Patient.

Mohammed Ayyad, Maram Albandak, Mansour Khaleel, Nabil C N Khalil, Muaath Itmaizeh

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mohammed AyyadInternal Medicine, Al-Quds University, Jerusalem, PSE.
Maram AlbandakInternal Medicine, Al-Quds University, Jerusalem, PSE.
Mansour KhaleelInternal Medicine, Al-Makassed Charitable Society Hospital, Jerusalem, PSE.
Nabil C N KhalilInternal Medicine, Al-Makassed Charitable Society Hospital, Jerusalem, PSE.
Muaath ItmaizehRheumatology, Al-Makassed Charitable Society Hospital, Jerusalem, PSE.
Al-Quds University · PSAl-Makassed Islamic Charitable Society Hospital · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ST-segment elevation myocardial infarction (STEMI) in young adults is a rare occurrence that requires a thorough investigation to determine the underlying cause. Herein, a young female patient presented with dull retrosternal chest pain associated with nausea and left arm numbness. Cardiac-specific troponin was elevated and the electrocardiogram revealed ST-segment elevation in the inferior wall leads indicative of myocardial infarction. The patient was started on dual antiplatelet therapy (DAPT) and emergency coronary angiography was performed, revealing a 20% stenosis in the left circumflex artery and evidence of a thrombotic lesion in the posterolateral branch (PLB), which was deemed unsuitable for intervention. During the diagnostic workup, the patient tested positive for antinuclear antibodies and was ultimately diagnosed with systemic lupus erythematosus (SLE) and antiphospholipid syndrome. This case highlights the rarity of STEMI as an initial presentation of SLE. It emphasizes the importance of considering autoimmune disorders in young patients with acute myocardial infarction and the need for a comprehensive evaluation and appropriate management in such cases.

Indexed as

acute coronary syndromeanti-double-stranded dna antibodies (anti-dsdna)antinuclear antibodies (ana)atherosclerosisautoimmune diseasedual-antiplatelet therapy (dapt)myocardial infarctionprimary pcistemisystemic lupus erythematosus

Identifiers

PMID37519572
PMCPMC10373106
OpenAlexW4382246456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.